Victrex (OTCMKTS:VTXPF) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

Separately, Zacks Investment Research raised Victrex from a “sell” rating to a “hold” rating in a research report on Thursday, August 16th.

Shares of VTXPF opened at $34.95 on Thursday. Victrex has a 52 week low of $31.49 and a 52 week high of $45.68.

Victrex Company Profile

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.

Read More: How a Put Option Works

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.